Cargando…
LASSBio-1135: A Dual TRPV1 Antagonist and Anti-TNF-Alpha Compound Orally Effective in Models of Inflammatory and Neuropathic Pain
LASSBio-1135 is an imidazo[1,2-a]pyridine derivative with high efficacy in screening models of nociception and inflammation, presumed as a weak COX-2 inhibitor. In order to tease out its mechanism of action, we investigated others possible target for LASSBio-1135, such as TNF-α and TRPV1, to better...
Autores principales: | Lima, Cleverton K. F., Silva, Rafael M., Lacerda, Renata B., Santos, Bruna L. R., Silva, Rafaela V., Amaral, Luciana S., Quintas, Luís E. M., Fraga, Carlos A. M., Barreiro, Eliezer J., Guimaraes, Marília Z. P., Miranda, Ana L. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062389/ https://www.ncbi.nlm.nih.gov/pubmed/24941071 http://dx.doi.org/10.1371/journal.pone.0099510 |
Ejemplares similares
-
Impairment of locomotor activity induced by the novel
N-acylhydrazone derivatives LASSBio-785 and LASSBio-786 in
mice
por: Silva, G.A.P., et al.
Publicado: (2013) -
Therapeutic effects of LASSBio-596 in an elastase-induced mouse model of emphysema
por: Padilha, Gisele A., et al.
Publicado: (2015) -
Evaluation of Functional Selectivity of Haloperidol, Clozapine, and LASSBio-579, an Experimental Compound With Antipsychotic-Like Actions in Rodents, at G Protein and Arrestin Signaling Downstream of the Dopamine D(2) Receptor
por: Silva, Rafaela R., et al.
Publicado: (2019) -
LASSBio-1586, an N-acylhydrazone derivative, attenuates nociceptive behavior and the inflammatory response in mice
por: Silva, Juliane Cabral, et al.
Publicado: (2018) -
LASSBio-897 Reduces Lung Injury Induced by Silica Particles in Mice: Potential Interaction with the A(2A) Receptor
por: Carvalho, Vinicius F., et al.
Publicado: (2017)